Swiss National Bank lifted its holdings in shares of Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 5.5% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,436,971 shares of the company's stock after buying an additional 180,671 shares during the period. Swiss National Bank owned 0.25% of Keurig Dr Pepper worth $117,613,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. ST Germain D J Co. Inc. acquired a new position in shares of Keurig Dr Pepper during the 1st quarter valued at $27,000. Continuum Advisory LLC grew its holdings in shares of Keurig Dr Pepper by 82.5% during the first quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock valued at $46,000 after buying an additional 602 shares in the last quarter. Global Trust Asset Management LLC acquired a new stake in Keurig Dr Pepper during the first quarter valued at $48,000. LRI Investments LLC boosted its position in Keurig Dr Pepper by 65.6% during the fourth quarter. LRI Investments LLC now owns 1,527 shares of the company's stock valued at $49,000 after purchasing an additional 605 shares during the last quarter. Finally, Riverview Trust Co boosted its position in Keurig Dr Pepper by 47.7% during the first quarter. Riverview Trust Co now owns 1,710 shares of the company's stock valued at $59,000 after purchasing an additional 552 shares during the last quarter. 93.99% of the stock is currently owned by institutional investors and hedge funds.
Keurig Dr Pepper Price Performance
Shares of NASDAQ:KDP traded up $0.19 during trading on Tuesday, hitting $34.81. 7,705,961 shares of the company were exchanged, compared to its average volume of 10,111,649. The business's 50 day moving average is $33.34 and its 200-day moving average is $33.47. The company has a market capitalization of $47.29 billion, a P/E ratio of 17.31, a price-to-earnings-growth ratio of 2.52 and a beta of 0.45. The company has a quick ratio of 0.40, a current ratio of 0.64 and a debt-to-equity ratio of 0.56. Keurig Dr Pepper, Inc has a 1-year low of $30.12 and a 1-year high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its quarterly earnings data on Thursday, July 24th. The company reported $0.49 earnings per share for the quarter, hitting the consensus estimate of $0.49. The company had revenue of $4.16 billion for the quarter, compared to analysts' expectations of $4.14 billion. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. Keurig Dr Pepper's revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.45 earnings per share. Equities analysts forecast that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.
Keurig Dr Pepper Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were issued a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date was Friday, June 27th. Keurig Dr Pepper's dividend payout ratio is currently 82.14%.
Analyst Ratings Changes
KDP has been the topic of a number of recent analyst reports. UBS Group dropped their price target on shares of Keurig Dr Pepper from $42.00 to $40.00 and set a "buy" rating on the stock in a research report on Thursday, July 17th. Argus initiated coverage on Keurig Dr Pepper in a research note on Wednesday, April 16th. They set a "buy" rating and a $40.00 price target on the stock. Barclays upped their price objective on Keurig Dr Pepper from $37.00 to $39.00 and gave the company an "overweight" rating in a research note on Monday, July 28th. HSBC upgraded Keurig Dr Pepper from a "hold" rating to a "buy" rating and upped their price objective for the company from $36.00 to $42.00 in a research note on Friday, April 25th. Finally, JPMorgan Chase & Co. decreased their price target on Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating on the stock in a research report on Thursday, July 17th. Two analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Keurig Dr Pepper presently has an average rating of "Moderate Buy" and a consensus price target of $39.77.
Get Our Latest Stock Report on KDP
Insider Buying and Selling
In other Keurig Dr Pepper news, insider Mary Beth Denooyer sold 12,000 shares of the stock in a transaction dated Thursday, July 17th. The shares were sold at an average price of $33.66, for a total value of $403,920.00. Following the completion of the sale, the insider owned 82,511 shares in the company, valued at approximately $2,777,320.26. This trade represents a 12.70% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Robert James Gamgort sold 208,000 shares of the business's stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $32.90, for a total transaction of $6,843,200.00. Following the completion of the transaction, the director directly owned 2,292,169 shares in the company, valued at $75,412,360.10. This trade represents a 8.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 672,000 shares of company stock worth $22,235,760 in the last quarter. Insiders own 1.00% of the company's stock.
About Keurig Dr Pepper
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Read More

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.